HealthMyne’s Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses
HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that...